No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
New Indication Alert: Genmab’s Epkinly® (Epcoritamab) Approved in Japan for R/R Follicular Lymphoma
On 20 February 2025, Genmab announced that Japan’s Ministry of Health, Labour and Welfare has approved Epkinly® (epcoritamab) for the treatment of patients with relapsed or refractory (R/R)